Healthy Clinical Trial
— ChroNuOfficial title:
Controlled Nutrition Trial on the Glycaemic Response to Morning and Evening Meals With High Glycemic Index Carbohydrates Among Students With Early and Late Chronotypes-The ChroNu Study
Verified date | December 2020 |
Source | Paderborn University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Several studies suggest that meal timing plays an important role in the development of obesity and metabolic diseases. Especially in the evening, a high consumption of carbohydrates, which greatly increase blood glucose levels (i.e. unfavourable carbohydrates with a higher glycaemic index (GI)), has been found to adversely affect glycaemic response. However, avoidance of (unfavourable) carbohydrate consumption appears to be particularly problematic for young adults due to its interference with the timing of social life and their chronotype. The chronotype describes individual differences in sleep timing on free days and is most delayed around the age of 20. Young adults are thus prone to be exposed to a dietary misalignment when socially determined schedules, such as early lectures at universities, collide with their biologically determined later chronotype. Therefore, it is hypothesized that dietary misalignment among young adults has detrimental short-term effects on the glucose metabolism. In this nutrition trial, dietary misalignment is induced by providing the same meal rich in carbohydrates with a high glycaemic index (GI) on two separate days at different times: breakfast at 7:00 is assumed to reflect a schedule potentially inducing dietary misalignment among later chronotypes. Vice versa, providing this meal at dinner (20:00) may cause dietary misalignment among earlier chronotypes. Adverse glycaemic responses are expected when the high GI meal is consumed at a time which is deviating from the schedule of the individual chronotype. A regular increase in postprandial glycaemia due to constant dietary misalignment may be important in the development of metabolic diseases.
Status | Completed |
Enrollment | 60 |
Est. completion date | December 18, 2020 |
Est. primary completion date | December 18, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 25 Years |
Eligibility | Inclusion Criteria: - Healthy students of Paderborn University - 18 - 25 years old at time of screening for the ChroNu cohort - 18,5 kg/m² < BMI > 30 kg/m² - Free of diseases requiring constant or chronic medical treatment (except for oral contraceptives) - Willingness to participate in the nutrition trial (8 days) including invasive measurements - Fluent knowledge of the German language Exclusion Criteria: - students studying nutrition science at the University Paderborn - regular smokers - pregnancy or lactation - chronic diseases: diabetes mellitus (all types), pre-diabetes, individuals with bleeding disorders (thrombocytopenia, haemophilia) - contact dermatitis to adhesive plaster or skin disease that prevents the participant from wearing the CGM - intake of medication which influence the chronotype: such as antidepressants or sleeping pills - shift work in the past 3 months - crossing of > 1-time zone in the past 3 months - strict vegetarians /vegans - individuals having an allergy or intolerance to food that is included in the diet |
Country | Name | City | State |
---|---|---|---|
Germany | Paderborn University | Paderborn | North-Rhine Westphalia |
Lead Sponsor | Collaborator |
---|---|
Paderborn University | German Diabetes Center, German Research Foundation, University of Bergen |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Blood lipids, inflammation marker, and glucose homeostasis | Blood lipids, markers of chronic inflammation, and glucose homeostasis will be measured from serum or plasma obtained from fasting whole blood samples. total cholesterol (mmol/L) triglycerides (mmol/L) LDL- cholesterol (mmol/L) HDL- cholesterol (mmol/L small-dense LDL (mmol/L) small-dense HDL (mmol/L) high-sensitivity C-reactive protein (mmol/L) Fasting blood glucose (mmol/L) |
7:30 on run-in day | |
Other | Insulin level | - fasting plasma insulin level (µE/mL) | 7:30 run-in day | |
Other | Liver enzymes | Alanine transaminase (U/L) ?- Glutamyltransferase (U/L) |
7:30 run-in day | |
Other | Clock gene expression | 7:30 run-in day | ||
Other | Sleep timing | Sleep timing (unit) will be determined using an accelerometer (Empatica E4) and manually kept diary during the 8 days of nutrition trial. This information will serve to to corroborate the chronotype of the participants. | 8 days | |
Other | Change in fat mass | Body composition is electronically analyzed using Bioimpedance Analysis (BIA) (mBCA 515, SECA). | at baseline (day 1) and after intervention (day 8) | |
Other | Change in Body Mass Index | Body Mass Index (BMI) is calculated by weight(kg) / height(m)²). Weight and height are measured electronically. | at baseline (day 1) and after intervention (day 8) | |
Primary | Differences in the 2-h pp glycaemic response between the high GI carbohydrate meal consumed for breakfast (7:00) and the high GI carbohydrate meal consumed for dinner (20:00). | 2 hour post prandial response (iAUC) is calculated as the incremental area under the curve of measurements taken within the two hours after the test meals. | 2 hour postprandial after test meals | |
Primary | Differences in the 2-h pp glycaemic variability between the high GI carbohydrate meal consumed for breakfast (7:00) and the high GI carbohydrate meal consumed for dinner (20:00). | the 2-h pp glycaemic variability (MAGE) is calculated as the mean amplitude of glycaemic excursions during the two hours after the test meals, i.e. both resemble summary measures calculated from repeated measurements taken the 2 h pp. | 2 hours postprandial after test meals | |
Secondary | Diurnal differences in the glycaemic response (iAUC) and in response to the high GI carbohydrates for dinner and the high GI carbohydrates for breakfast. | 24 hour post prandial response (iAUC) is calculated as the incremental area under the curve of measurements taken within the 24 hours after the test meals. | 24 hours after test meals | |
Secondary | Diurnal differences in the glycaemic variability (MAGE) in response to the high GI carbohydrates for dinner and the high GI carbohydrates for breakfast. | 24-h pp glycaemic variability (MAGE) is calculated as the mean amplitude of glycaemic excursions during the 24 hours after the test meals, i.e. both resemble summary measures calculated from repeated measurements taken the 24 h pp. | 24 hours after test meals |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |